Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mather

Showing results (181-190 of 504) with videos related to

Pageof 51
Sort By:
The Journal of Spinal Cord Medicine|May 3, 2011
Influence of motor complete spinal cord injury on visceral and subcutaneous adipose tissue measured by multi-axial magnetic resonance imagingAshraf S Gorgey, Kieren J Mather, Hunter J Poarch, et al.
British Journal of Anaesthesia|April 1, 1990
Postoperative analgesia after paediatric orchidopexy: evaluation of a bupivacaine-morphine mixtureA R Wolf, D Hughes, A Wade, et al.
Circulation|December 12, 2001
Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers: randomized evaluation of rofecoxib versus naproxen on endothelium-dependent vasodilatationS Verma, S R Raj, L Shewchuk, et al.
Diabetes|November 28, 2002
Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetesKieren J Mather, Bahram Mirzamohammadi, Amale Lteif, et al.
Statistics in Medicine|September 1, 1990
A method for the evaluation of dose-toxicity relationships in clinical trialsF J Mather, R M Simon, G M Clark, et al.
European Journal of Nuclear Medicine|September 28, 2000
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivativesC Decristoforo, S J Mather, W Cholewinski, et al.
European Journal of Nuclear Medicine|November 18, 2000
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotideC Decristoforo, W Cholewinski, E Donnemiller, et al.
Diabetes/Metabolism Research and Reviews|February 11, 2011
Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humansK A Han, Y Patel, A A Lteif, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2005
(99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agentT Gmeiner Stopar, I Mlinaric-Rascan, J Fettich, et al.
Cancer Treatment Reports|June 1, 1987
Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studiesF J Mather, R M Simon, G M Clark, et al.
Pageof 51

Showing results (181-190 of 504) with videos related to

Sort By:
Pageof 51
The Journal of Spinal Cord Medicine|May 3, 2011
Influence of motor complete spinal cord injury on visceral and subcutaneous adipose tissue measured by multi-axial magnetic resonance imagingAshraf S Gorgey, Kieren J Mather, Hunter J Poarch, et al.
British Journal of Anaesthesia|April 1, 1990
Postoperative analgesia after paediatric orchidopexy: evaluation of a bupivacaine-morphine mixtureA R Wolf, D Hughes, A Wade, et al.
Circulation|December 12, 2001
Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers: randomized evaluation of rofecoxib versus naproxen on endothelium-dependent vasodilatationS Verma, S R Raj, L Shewchuk, et al.
Diabetes|November 28, 2002
Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetesKieren J Mather, Bahram Mirzamohammadi, Amale Lteif, et al.
Statistics in Medicine|September 1, 1990
A method for the evaluation of dose-toxicity relationships in clinical trialsF J Mather, R M Simon, G M Clark, et al.
European Journal of Nuclear Medicine|September 28, 2000
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivativesC Decristoforo, S J Mather, W Cholewinski, et al.
European Journal of Nuclear Medicine|November 18, 2000
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotideC Decristoforo, W Cholewinski, E Donnemiller, et al.
Diabetes/Metabolism Research and Reviews|February 11, 2011
Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humansK A Han, Y Patel, A A Lteif, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2005
(99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agentT Gmeiner Stopar, I Mlinaric-Rascan, J Fettich, et al.
Cancer Treatment Reports|June 1, 1987
Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studiesF J Mather, R M Simon, G M Clark, et al.
Pageof 51